{
    "clinical_study": {
        "@rank": "6708", 
        "arm_group": [
            {
                "arm_group_label": "gabapentin", 
                "arm_group_type": "Active Comparator"
            }, 
            {
                "arm_group_label": "Pregabalin", 
                "arm_group_type": "Active Comparator"
            }
        ], 
        "brief_summary": {
            "textblock": "Pregabalin is claimed to have superior analgesic effect at lower doses and better\n      pharmacological profile as compared to gabapentin esp. in perioperative pain control after\n      major surgeries like intervertebral disc surgery.\n\n      The investigators found that pregabalin is equivalent to gabapentin for relief of\n      post-operative pain at a lower dose in patients undergoing intervertebral disc surgery."
        }, 
        "brief_title": "Pregabalin Compared to Gabapentin for Pain Control in Lumbar Disc Surgery", 
        "completion_date": {
            "#text": "October 2011", 
            "@type": "Actual"
        }, 
        "condition": "Intervertebral Disc Prolapse", 
        "condition_browse": {
            "mesh_term": [
                "Prolapse", 
                "Intervertebral Disk Displacement"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  30-60 years age\n\n          -  Any gender\n\n          -  elective micro discectomy for intervertebral disc prolapse\n\n        Exclusion Criteria:\n\n          1. micro discectomy at two or more vertebral levels,\n\n          2. Instrumentation i.e. pedicle screw fixation, hooks etc.,\n\n          3. history of steroids or alcohol use,\n\n          4. Multiple co-morbids i.e. renal failure, chronic liver disease,\n\n          5. use of anticonvulsant drugs,\n\n          6. Spinal deformity,\n\n          7. Obesity (BMI >30), 8) inability to understand and respond VAS and\n\n        9) patients with known allergy to GABA analogues."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "60 Years", 
            "minimum_age": "30 Years"
        }, 
        "enrollment": {
            "#text": "78", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "April 19, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02120703", 
            "org_study_id": "173-SUR-ERC-10"
        }, 
        "intervention": [
            {
                "arm_group_label": "Pregabalin", 
                "description": "Pregablin 75 mg per oral two times a day", 
                "intervention_name": "Pregabalin", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "gabapentin", 
                "description": "Gabapentin 200 mg twice daily per oral", 
                "intervention_name": "Gabapentin", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Gabapentin", 
                "Pregabalin"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Pregabalin", 
            "gabapentin", 
            "microdiscectomy", 
            "pain"
        ], 
        "lastchanged_date": "April 22, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Karachi", 
                    "country": "Pakistan", 
                    "state": "Sind", 
                    "zip": "75300"
                }, 
                "name": "The Aga Khan University Hospital"
            }
        }, 
        "location_countries": {
            "country": "Pakistan"
        }, 
        "number_of_arms": "2", 
        "official_title": "Gabapentin vs. Pregabalin for Post Operative Pain in Lumbar Microdiscectomy: a Randomized Controlled Trial.", 
        "overall_official": {
            "affiliation": "The Aga Khan University Hospital, Karachi, Pakistan", 
            "last_name": "Mohsin Qadeer, FCPS", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Pakistan: Research Ethics Committee", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "October 2011", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Pain measurement using Visual Analogue Score at 24 hours and 7th day of surgery", 
            "measure": "Pain", 
            "safety_issue": "No", 
            "time_frame": "7 days"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02120703"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Aga Khan University", 
            "investigator_full_name": "Ghulam Murtaza", 
            "investigator_title": "Dr.", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Aga Khan University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Aga Khan University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "February 2011", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Supportive Care", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}